Literature DB >> 1424301

Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats.

H Hoshino1, S Sugiyama, A Ohara, H Goto, Y Tsukamoto, T Ozawa.   

Abstract

1. The role of prostanoids in experimental colitis with trinitrobenzene sulfonic acid (TNBS) in rats was investigated. The effects of cyclosporine A (CsA) on the development of experimental colitis were also examined. 2. Five kinds of prostanoids were detected in rat colonic tissue by high performance liquid chromatography. These were 6-keto-prostaglandin (PG) F1 alpha, PGF2 alpha, PGE2, PGD2 and thromboxane B2. 3. In TNBS-induced experimental colitis, all prostanoid concentrations except PGD2 increased, although the time courses differed from each other. 4. Medication with indomethacin markedly reduced prostanoid concentrations in TNBS-induced colitis. However, indomethacin did not show any effect on damage scores. 5. Cyclosporine A reduced damage scores 14 days after TNBS treatment, and the protective effects were observed, whereas CsA did not affect colonic tissue prostanoid concentrations. 6. Prostanoids might be produced secondarily in the genesis of TNBS-induced colitis, although they may attenuate the inflammatory response. It was also suggested that CsA was likely to have therapeutic effects on experimental colitis by inhibiting the immune reaction with TNBS, which induced the chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424301     DOI: 10.1111/j.1440-1681.1992.tb00409.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

1.  Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig.

Authors:  O Jeanneton; M Delvaux; Y Langlois; P Le Bars; J Le Bars; M B Delisle; J Frexinos; L Bueno
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis.

Authors:  R Newman; N Cuan; T Hampartzoumian; S J Connor; A R Lloyd; M C Grimm
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis.

Authors:  A Miranda; E Nordstrom; A Mannem; C Smith; B Banerjee; J N Sengupta
Journal:  Neuroscience       Date:  2007-08-23       Impact factor: 3.590

4.  Phorbol myristate acetate ex vivo model of enhanced colonic epithelial permeability. Reactive oxygen metabolite and protease independence.

Authors:  M C Berin; M G Buell
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

5.  Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.

Authors:  P Desreumaux; L Dubuquoy; S Nutten; M Peuchmaur; W Englaro; K Schoonjans; B Derijard; B Desvergne; W Wahli; P Chambon; M D Leibowitz; J F Colombel; J Auwerx
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

Review 6.  Choosing an Animal Model for the Study of Functional Dyspepsia.

Authors:  Yang Ye; Xue-Rui Wang; Yang Zheng; Jing-Wen Yang; Na-Na Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-12

7.  Simultaneous Quantitation of Lipid Biomarkers for Inflammatory Bowel Disease Using LC-MS/MS.

Authors:  Yashpal S Chhonker; Shrey Kanvinde; Rizwan Ahmad; Amar B Singh; David Oupický; Daryl J Murry
Journal:  Metabolites       Date:  2021-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.